Skip to main content
. 2023 Jan 22;11(2):311. doi: 10.3390/biomedicines11020311

Figure 6.

Figure 6

Impact of PD-L1 tumor expression and CD3-positive tumor-infiltrating lymphocytes on the overall survival rate of glioblastoma patients. (a) PD-L1-positive (expression in ≥1% of tumor cells) versus PD-L1-negative tumors; (b) high CD3 expression (≥median) versus low expression (<median).